Imaging of gefitinib-related interstitial lung disease: Multi-institutional analysis by the West Japan Thoracic Oncology Group
- 31 May 2006
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 52 (2), 135-140
- https://doi.org/10.1016/j.lungcan.2006.02.002
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Acute gefitinib-induced pneumonitisInternational Journal of Clinical Oncology, 2004
- Severe acute interstitial pnuemonia and gefitinibLung Cancer, 2004
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancerLung Cancer, 2003
- Severe acute interstitial pneumonia and gefitinibThe Lancet, 2003
- Drug-induced Pneumonitis: Thin-Section CT Findings in 60 PatientsRadiology, 2002
- Drug-induced Lung Disease: High-resolution CT and Histological FindingsClinical Radiology, 2002
- High-resolution CT of drug-induced lung diseaseRadiologic Clinics of North America, 2002
- Acute lung injury as a possible adverse drug reaction related to gefitinib.European Respiratory Journal, 2002
- High-resolution computed tomography of drug-induced lung diseaseClinical Radiology, 1992